| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Clinical Controls
1 company
Kevin S Gould last filed a Form 4 in October 2017, as SVP Clinical Controls at TECH. Kevin S Gould's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,355 shares of TECH. The TECH filings lean toward selling, a net 524 shares.
Kevin S Gould has 6 Form 4 filings on record from January 2016 to October 2017, all as SVP Clinical Controls at Bio-Techne (TECH), 2016–2017.
The 10 reported transactions were 7 option or other derivative awards, 2 tax withholdings and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $58K.
The only open-market sale was 524 shares of TECH at an average $110.50 on September 8, 2016, about $58K.
Shares as reported in the last Form 4 for each company; the most recent is from October 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2016 | TECH Bio-Techne Corp | SVP Clinical Controls | Sell | 524 | $110.50 | $57,903.57 | -23.9% |